compound tirzepatide stopping Important Update: Compounded Will No Longer Be Available After March 19 FDA Clarifies Compounding Rules as

Earlier this month, the FDA posted four warning letters to companies that have introduced unapproved GLP-1s, such as semaglutide, tirzepatide, and retatrutide, into interstate commerce

In the STEP-1 trial (N=1,961), 44.2% of participants receiving semaglutide 2.4 mg reported nausea compared to 17.4% on placebo [1]

Inoue S, et al

Bringing a copy of your prescription or a letter from your healthcare provider can smooth the security process, though TSA generally recognizes standard medication supplies without issue

See how to store peptides for proper handling on arrival

The problem surfaced in clinical trials run in 1992 by Mojsov and David Nathan, a physician and expert in type 2 diabetes at MGH, and those of Holst and Nauck (Molteni, Chen)